|
1
|
Lal BK, Zhou W, Li Z, Kyriakides T,
Matsumura J, Lederle FA and Freischlag J: OVER Veterans Affairs
Cooperative Study Group: Predictors and outcomes of endoleaks in
the Veterans Affairs Open Versus Endovascular Repair (OVER) trial
of abdominal aortic aneurysms. J Vasc Surg. 62:1394–1404. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li C, Li YS, Xu M, Wen SH, Yao X, Wu Y,
Huang CY, Huang WQ and Liu KX: Limb remote ischemic preconditioning
for intestinal and pulmonary protection during elective open
infrarenal abdominal aortic aneurysm repair: A randomized
controlled trial. Anesthesiology. 118:842–852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang X, Chen YX, Zhang B, Jiang YX, Liu
CW, Zhao RN, Wu Q and Zhang DM: Contrast-enhanced ultrasound in
detecting endoleaks with failed computed tomography angiography
diagnosis after endovascular abdominal aortic aneurysm repair. Chin
Med J (Engl). 128:2491–2497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Karlsson L, Bergqvist D, Lindbäck J and
Pärsson H: Expansion of small-diameter abdominal aortic aneurysms
is not reflected by the release of inflammatory mediators IL-6,
MMP-9 and CRP in plasma. Eur J Vasc Endovasc Surg. 37:420–424.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jones KG, Brull DJ, Brown LC, Sian M,
Greenhalgh RM, Humphries SE and Powell JT: Interleukin-6 (IL-6) and
the prognosis of abdominal aortic aneurysms. Circulation.
103:2260–2265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kokje VBC, Gäbel G, Koole D, Northoff BH,
Holdt LM, Hamming JF and Lindeman JHN: IL-6: A Janus-like factor in
abdominal aortic aneurysm disease. Atherosclerosis. 251:139–146.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liao M, Xu J, Clair AJ, Ehrman B, Graham
LM and Eagleton MJ: Local and systemic alterations in signal
transducers and activators of transcription (STAT) associated with
human abdominal aortic aneurysms. J Surg Res. 176:321–328. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Banerjee K and Resat H: Constitutive
activation of STAT3 in breast cancer cells: A review. Int J Cancer.
138:2570–2578. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang YH, Yang HY, Huang SW, Ou G, Hsu YF
and Hsu MJ: Interleukin-6 induces vascular endothelial growth
factor-C expression via Src-FAK-STAT3 signaling in lymphatic
endothelial cells. PLoS One. 11:e01588392016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bode JG, Albrecht U, Häussinger D,
Heinrich PC and Schaper F: Hepatic acute phase proteins-regulation
by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk
with NF-κB-dependent signaling. Eur J Cell Biol. 91:496–505. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He G and Karin M: NF-κB and STAT3-key
players in liver inflammation and cancer. Cell Res. 21:159–168.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dharmapatni AA, Cantley MD, Marino V,
Perilli E, Crotti TN, Smith MD and Haynes DR: The X-linked
inhibitor of apoptosis protein inhibitor embelin suppresses
inflammation and bone erosion in collagen antibody induced
arthritis mice. Mediators Inflamm. 2015:5640422015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marsh JL, Jackman CP, Tang SN, Shankar S
and Srivastava RK: Embelin suppresses pancreatic cancer growth by
modulating tumor immune microenvironment. Front Biosci (Landmark
Ed). 19:113–125. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu CL, Zheng B, Pei JH, Shen SJ and Wang
JZ: Embelin induces apoptosis of human gastric carcinoma through
inhibition of p38 MAPK and NF-κB signaling pathways. Mol Med Rep.
14:307–312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang CK, Luo J, Lai KP, Wang R, Pang H,
Chang E, Yan C, Sparks J, Lee SO, Cho J and Chang C: Androgen
receptor promotes abdominal aortic aneurysm development via
modulating inflammatory interleukin-1α and transforming growth
factor-β1 expression. Hypertension. 66:881–891. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lederle FA, Freischlag JA, Kyriakides TC,
Matsumura JS, Padberg FT Jr, Kohler TR, Kougias P, Jean-Claude JM,
Cikrit DF and Swanson KM: OVER Veterans Affairs Cooperative Study
Group: Long-term comparison of endovascular and open repair of
abdominal aortic aneurysm. N Engl J Med. 367:1988–1997. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang GJ and Carpenter JP: Endologix
Investigators: The powerlink system for endovascular abdominal
aortic aneurysm repair: Six-year results. J Vasc Surg. 48:535–545.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mahmoud KM and Ammar AS: effect of
N-acetylcysteine on cardiac injury and oxidative stress after
abdominal aortic aneurysm repair: A randomized controlled trial.
Acta Anaesthesiol Scand. 55:1015–1021. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takagi H and Umemoto T: The association
between body mass index and abdominal aortic aneurysm growth: A
systematic review. Vasa. 45:119–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bruggink JL, Tielliu IF, Zeebregts CJ and
Pol RA: Mesenteric ischemia after abdominal aortic aneurysm repair:
A systemic review. J Cardiovasc Surg (Torino). 55:759–765.
2014.PubMed/NCBI
|
|
21
|
Mussa FF: Screening for abdominal aortic
aneurysm. J Vasc Surg. 62:774–778. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bergqvist D, Lindeman JH, Lindholt JS and
Björck M: Antimicrobial treatment to impair expansion of abdominal
aortic aneurysm (AAA): A systematic review of the clinical
evidence. Curr Vasc Pharmacol. 11:288–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Honjo H, Kumagai Y, Ishiguro T, Imaizumi
H, Ono T, Suzuki O, Ito T, Haga N, Kuwabara K, Sobajima J, et al:
Heterotopic mesenteric ossification after a ruptured abdominal
aortic aneurism: Case report with a review of literatures. Int
Surg. 99:479–484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sbarzaglia P, Grattoni C, Oshoala K,
Castriota F, D'Alessandro G and Cremonesi A: AorfixTM device for
abdominal aortic aneurysm with challenging anatomy. J Cardiovasc
Surg (Torino). 55:61–70. 2014.PubMed/NCBI
|
|
25
|
Khashram M, Hider PN, Williman JA, Jones
GT and Roake JA: Does the diameter of abdominal aortic aneurysm
influence late survival following abdominal aortic aneurysm repair?
A systematic review and meta-analysis. Vascular. 24:658–667. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Choudhury S, Gupta P, Ghosh S, Mukherjee
S, Chakraborty P, Chatterji U and Chattopadhyay S: Arsenic-induced
dose-dependent modulation of the NF-κB/IL-6 axis in thymocytes
triggers differential immune responses. Toxicology. 357–358:85–96.
2016. View Article : Google Scholar
|
|
27
|
Lin C, Wang L, Wang H, Yang L, Guo H and
Wang X: Tanshinone IIA inhibits breast cancer stem cells growth in
vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling
pathways. J Cell Biochem. 114:2061–2070. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma W, Sze KM, Chan LK, Lee JM, Wei LL,
Wong CM, Lee TK, Wong CC and Ng IO: RhoE/ROCK2 regulates
chemoresistance through NF-κB/IL-6/ STAT3 signaling in
hepatocellular carcinoma. Oncotarget. 7:41445–41459.
2016.PubMed/NCBI
|
|
29
|
Duellman T, Warren CL, Peissig P, Wynn M
and Yang J: Matrix metalloproteinase-9 genotype as a potential
genetic marker for abdominal aortic aneurysm. Circ Cardiovasc
Genet. 5:529–537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Adovasio R, Calvagna C, Sgorlon G, Zamolo
F, Mearelli F, Biolo G, Grassi G and Fiotti N: Growth rate of small
abdominal aortic aneurysms and genetic polymorphisms of matrix
metalloProteases-1, −3 and −9. Int J Angiol. 25:93–98. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tazume H, Miyata K, Tian Z, Endo M,
Horiguchi H, Takahashi O, Horio E, Tsukano H, Kadomatsu T,
Nakashima Y, et al: Macrophage-derived angiopoietin-like protein 2
accelerates development of abdominal aortic aneurysm. Arterioscler
Thromb Vasc Biol. 32:1400–1409. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang LY, Tu YF, Lin YC and Huang CC: CXCL5
signaling is a shared pathway of neuroinflammation and blood-brain
barrier injury contributing to white matter injury in the immature
brain. J Neuroinflammation. 13:62016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Madalli S, Beyrau M, Whiteford J, Duchene
J, Nandhra Singh I, Patel NS, Motwani MP, Gilroy DW, Thiemermann C,
Nourshargh S and Scotland RS: Sex-specific regulation of chemokine
Cxcl5/6 controls neutrophil recruitment and tissue injury in acute
inflammatory states. Biol Sex Differ. 6:272015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu X, Qiao Y, Liu W, Wang W, Shen H, Lu
Y, Hao G, Zheng J and Tian Y: CXCL5 is a potential diagnostic and
prognostic marker for bladder cancer patients. Tumour Biol.
37:4569–4577. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gao Y, Guan Z, Chen J, Xie H, Yang Z, Fan
J, Wang X and Li L: CXCL5/CXCR2 axis promotes bladder cancer cell
migration and invasion by activating PI3K/AKT-induced upregulation
of MMP2/MMP9. Int J Oncol. 47:690–700. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song J, Wu C, Zhang X and Sorokin LM: In
vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2
and MMP-9 promotes early neutrophil recruitment in IL-1β-induced
peritonitis. J Immunol. 190:401–410. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang DJ, Chang YY, Lin HW, Chen YC, Hsu SH
and Lin JT: Inhibitory effect of litchi (Litchi chinensis Sonn.)
flower on lipopolysaccharide-induced expression of proinflammatory
mediators in RAW264.7 cells through NF-κB, ERK, and JAK2/STAT3
inactivation. J Agric Food Chem. 62:3458–3465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hendrayani SF, Al-Harbi B, Al-Ansari MM,
Silva G and Aboussekhra A: The inflammatory/cancer-related
IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains
the active state of breast myofibroblasts. Oncotarget.
7:41974–41985. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hsieh YJ, Tseng SP, Kuo YH, Cheng TL,
Chiang CY, Tzeng YM and Tsai WC: Ovatodiolide of anisomeles indica
exerts the anticancer potential on pancreatic cancer cell lines
through STAT3 and NF-κB regulation. Evid Based Complement Alternat
Med. 2016:86803722016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dai Y, Jiao H, Teng G, Wang W, Zhang R,
Wang Y, Hebbard L, George J and Qiao L: Embelin reduces
colitis-associated tumorigenesis through limiting IL-6/STAT3
signaling. Mol Cancer Ther. 13:1206–1216. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu YF, Bai YQ and Qi M: Daidzein
attenuates abdominal aortic aneurysm through NF-κB, p38MAPK and
TGF-β1 pathways. Mol Med Rep. 14:955–962. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tsai SH, Huang PH, Peng YJ, Chang WC, Tsai
HY, Leu HB, Chen JW and Lin SJ: Zoledronate attenuates angiotensin
II-induced abdominal aortic aneurysm through inactivation of
Rho/ROCK-dependent JNK and NF-κB pathway. Cardiovasc Res.
100:501–510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yu Q, Zeng K, Ma X, Song F, Jiang Y, Tu P
and Wang X: Resokaempferol-mediated anti-inflammatory effects on
activated macrophages via the inhibition of JAK2/STAT3, NF-κB and
JNK/p38 MAPK signaling pathways. Int Immunopharmacol. 38:104–114.
2016. View Article : Google Scholar : PubMed/NCBI
|
